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New Zealand black (NZB)  mice and their Fx hybrids (NZB x W) spontaneously 
develop a disease that closely resembles human systemic lupus erythematosus (SLE) 1 
(1,  2).  The  immunologic abnormalities of this  disorder  are  characterized  by  the 
formation of several  types of autoantibodies and immune complex (1C) glomerulo- 
nephritis (3-5). Endogenous retroviruses and their gene products have been implicated 
in the pathogenesis of murine SLE (6,  7), partially because of the remarkably high 
concentrations of the retroviral envelope glycoprotein, gp70, found in sera of NZ mice 
(6, 8, 9), and partly because gp70 is deposited in diseased glomeruli along with host 
immunoglobulins (Ig) and complement and nuclear antigens (4, 6, 7). Like NZB and 
NZB  x  W  mice,  the  newly developed  murine  strains,  MRL/1  and  BXSB,  also 
spontaneously develop an SLE-like  disease and although their serum levels of gp70 
are not as high as those of NZ mice, gp70 is deposited in diseased  glomeruli (10). 
Considering that serum gp70 may form gp70-anti-gp70  ICs and, subsequently, deposit 
in glomerular lesions, we compared the four strains of SLE-prone mice to several 
immunologically normal murine strains with comparable levels of serum gp70 for the 
presence  of circulating ICs. For this purpose, the molecular size of serum gp70 was 
determined by sucrose  density gradient analysis, and the amount of rapidly sedi- 
meriting gp70 which was found bound to Ig was quantitated throughout the course 
of disease. 
We found that sera from all SLE mice contained a heavy form of gp70 complexed 
to Ig, and that these complexes appeared with the onset of renal disease and persisted 
throughout its course. By contrast, the normal strains of mice with comparable serum 
gp70 levels did not have heavy gp70. 
Materials and Methods 
Mice.  Of the SLE-prone strains, NZB and NZW mice were originally obtained from the 
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Laboratory Animals Centre, Medical Research Council, Surrey, England, and since 1965 have 
been maintained by brother-sister matings at Scripps Clinic and Research Foundation. Mating 
of NZB females with NZW males produced the NZB x W  hybrids. The inbred strains BXSB, 
MRL/1, and MRL/n were obtained from the research colony of Dr. E. D. Murphy of The 
Jackson Laboratory, Bar Harbor, Maine. BXSB is a recombinant inbred strain derived from 
crossing  a  C57BL/6  female  and  an  SB/Le  male.  Nearly  100% of the  BXSB  develop  a 
spontaneous progressive lethal SLE-like disease affecting males much earlier than females. The 
MRL substrains were derived mainly from strain LG/J with contributions from AKR/J, C3H/ 
Di, and C57BL/6. A spontaneous autosomal recessive mutation, lpr (lymphoproliferation) gene, 
producing massive T-cell proliferation and an early onset SLE-like syndrome was first observed 
at the 12th generation of inbreeding (11).  Two inbred substrains that shared ~= 89% of their 
genomes were  developed:  MRL/1  (lpr/lpr),with  massive lymphoproliferation, and  MRL/n 
(+/+),  without lpr and with late-life SLE. The immunologically normal strains, C57BL/6, 
BALB/c, and C3H mice were purchased from Leonell C.  Strong Research Foundation, San 
Diego, Calif. AKR, DBA/2, LG/J, and  129 mice came from The Jackson Laboratories. Blood 
samples were collected by orbital sinus puncture, and the sera were stored at -20°C until use. 
Retroviral Envelope Glycoprotein, gp70.  gp70 of Rauscher murine leukemia virus (MuLV) and 
NZB xenotrope virus prepared as described by Strand and August (12) were kindly provided 
by Dr. J. Elder (the Scripps Clinic and Research Foundation). gp70 from AKR ecotrope virus 
and major structural protein p30 of Rauscher murine leukemia virus (MuLV) were a gift from 
Dr. A. F. Esser and Dr. R. M. Bartholomew (the Scripps Clinic and Research Foundation). 
Antisera.  Goat anti-feline leukemia virus (FeLV) antisera were obtained from the National 
Cancer  Institute.  Anti-NZB  xenotrope  virus  antibodies  were  raised  in  goats  by  repeated 
injections of virus in Freund's adjuvant. Anti-mouse IgG and anti-goat IgG antibodies came 
from rabbits immunized by repeated injections of each respective IgG (Miles Laboratories, Inc., 
Miles Research Products, Elkhart, Ind.) in Freund's adjuvant. Monospecific rabbit anti-mouse 
IgG antiserum was purchased from Litton Bionetics, Kensington, Md. 
Radiolabeling Procedures.  gp70  from  Rauscher  MuLV,  NZB  xenotropic  virus  and  AKR 
ecotrope virus were labeled with radioactive iodine (125I) by the chloramine T  method  (13). 
Single-stranded DNA (ssDNA) was labeled with a25I by the method of Commerford (14). 
Radioimmunoassayfor gp70 and p30.  The concentrations of gp70 in serum samples, gradient 
fractions, or eluates from kidneys were determined by inhibiting the binding of goat anti-FeLV 
antibody to l~SI-labeled gp 70 from Rauscher MuLV. For the radioimmunoassay, 0.05 ml of test 
samples diluted in 0.1  M  borate buffer (pH 8.0)  containing 10% normal rabbit serum (NRS), 
1% normal goat serum and 0.01%  Triton X-100  (Rohm & Haas Co., Philadelphia, Pa.) was 
added to 0.025 ml of goat anti-FeLV antiserum diluted in the same buffer. 0.025 ml t25I-labeled 
Rauscher MuLV gp70 (1  ng) in borate buffer containing 0.2%  bovine serum albumin (BSA) 
was added to these mixtures. After an overnight incubation at room temperature, 0.1  ml of 
rabbit anti-goat IgG antiserum which was diluted in borate buffer (sufficient to precipitate > 
95% of IgG present in the reaction mixtures) was added, and incubation continued at 37°C for 
30 min, followed by an additional 30-min incubation at 4°C. In the absence of the competing 
viral antigen, -  40-50% specific precipitation of 12~I-Rauscher  MuLV gp70 was obtained. A 
standard inhibition curve was established with the buffer containing known amounts of gp70 
from Scripps leukemia virus (7) and the concentration of gp70 present in tested samples was 
estimated by reference to the standard curve. In some experiments, the concentration of gpT0 
in samples was determined by a similar radioimmunoassay with ~2~I-labeled NZB xenotropic 
gp70 and goat anti-NZB xenotropic virus antibodies, gp70 of NZB xenotropic virus was used 
as reference antigen for the latter radioimmunoassay. 
To  determine  the  amounts  of gp70  bound  to  Ig,  sera  were  depleted of Ig by  immune 
precipitation with rabbit anti-mouse IgG antisera, in which anti-goat IgG activity was preab- 
sorbed by goat IgG-coated immunoabsorbent columns because anti-goat IgG activity interferes 
with the radioimmunoassay for gp70. After the removal of Ig precipitates by centrifugation, the 
amount of gp70 in the supernate was determined. As a control, sera were treated with NRS. 
From  the concentrations of gp70  in  both samples, the  amounts  of gp70 bound  to  Ig were 
calculated. 
The absorption of serum gp70 by Staphylococcus aureus protein A  (Staph A, provided by Dr. SHOZO  IZUI ET AL.  1 101 
J.  Elder) was carried out as follows. 0.2 ml of sera diluted  1/10  in 2 mg/ml BSA in borate 
buffer was incubated with 0.05 ml washed, packed Staph A pretreated with formaldehyde for 
30 min at room temperature. 
Concentrations of p30 in gradient fractions were determined in a blocking assay using ~25I- 
Rauscher MuLV p30 and goat anti-MuLV p30 antibodies (provided by Dr. R. V. Glides of 
Flow Laboratories, Inc., Rockville, Md.) as described by Parks and Scolnik (15). 
Radioimmunologic Detection of Anti-gp 70 and Anti-DNA Antibodies.  The presence of antibodies to 
AKR ecotropic gp70, Rauscher MuLV gp70, or NZB xenotropie gp70 was determined by using 
a  radioimmunoassay in which the primary binding to each of these retroviral gp70s labeled 
with x2nI was followed by precipitation with rabbit anti-mouse IgG antisera. 0.005 ml of test 
serum, diluted 1/10 in borate buffer, was incubated with 0.025 ml of 125I-gp70 (1 ng) overnight 
at room temperature. Then, 0.1 ml of rabbit anti-mouse IgG antisera (sufficient to precipitate 
>  95% of the IgG) was added, and mixtures were incubated at 37°C for 30 min and at 4°C for 
30 rain. The results are expressed as the percentage of x2SI-gp70 specifically precipitated after 
correction for the nonspecific precipitation which was obtained from a pooled serum of NZB 
mice that did not contain any anti-gp70 activity (8,  16). 
Serum levels of anti-ssDNA antibodies were determined by using a modification of the Farr 
DNA-binding radioimmunoassay as described previously (17).  The results are expressed as a 
percentage of 20 ng of ~2SI-ssDNA precipitated by 0.01  ml serum at 50% saturated ammonium 
sulfate. The  normal  mean  value of 12SI-ssDNA precipitation, assessed by testing sera from 
normal mice of five different strains (AKR, BALB/c, C3H, C57BL/6, and DBA/2), was 8.5 
:t: 2.8% (1 SD). 
Sucrose Density Gradient Ultracentrifugation.  The sedimentation characteristics of gp70  from 
serum or renal eluates was determined by using sucrose density ultracentrifugation. Samples of 
0.05-0.15  ml were layered on 5-20%  (wt/vol) linear sucrose gradients in 0.01  M  phosphate- 
buffered saline, pH 7.0 (PBS) and centrifuged at 36,000 rpm for 15 h at 4°C with a SW60 rotor 
in a Beckman L-75 ultracentrifuge (Beckman Instruments, Inc., Fullerton, Calif.). The positions 
of IgM, IgG, or gp70 were established by radioactive markers, then the gradients were divided 
into  12 or  15  fractions. Each fraction was radioimmunoassayed for the presence of gp70.  In 
some experiments, sera were layered on a  5-20% sucrose gradient in PBS containing 0.5  M 
KSCN and centrifuged at 36,000 rpm for  15 h  at 4°C. The 8 or 12 fractions obtained from 
KSCN-containing gradients were immediately dialyzed against PBS before the determination 
of the gp70 content by the radioimmunoassay. IgG was detected in gradient fractions by radial 
double immunodiffusion with monospecific rabbit anti-mouse 7S IgG antisera. 
Partial Purification of Serum gp70.  Serum  gp70  was  partially purified by affinity column 
chromatography. Pooled sera from NZB, NZB x W, MRL/1, or BXSB mice were applied to a 
column containing concanavalin A-coupled Sepharose 4B (Pharmacia Fine Chemicals, Div. of 
Pharmacia Inc., Piscataway, N. J.). Bound gp70 was eluted by 0.1 M a-methyl-n-mannoside in 
PBS, concentrated, and dialyzed against PBS. 
Elution of Kidney-Fixed  gp70 and Ig.  Renal eluates were prepared as described previously (18). 
Briefly, kidneys from each of the SLE strains  (NZB, NZB x  W, MRL/1,  and  BXSB)  were 
pooled, cut into small pieces, and washed extensively with PBS overnight at 4°C. The tissues 
were homogenized and  washed  five times by centrifugation in  PBS.  The  precipitates were 
resuspended in PBS containing Mg  +÷, digested with DNase, and eluted with 2.5 M  KSCN in 
PBS.  Obtained eluates were  concentrated  with  a  Diaflo ultrafiltration membrane  (PMI0, 
Amicon Corp., Scientific Sys. Div., Lexington, Mass.)  in a  microfiltration system. The  IgG 
concentration was determined by radial immunodiffusion in agar (19). 
Results 
Retroviral gpTO and Anti-gp70  Antibodies in Sera.  Levels of gp70 were determined in 
sera  from  four  strains  of mice  which  were  considered  immunologically abnormal 
because  of their  predisposition  toward  SLE  (NZB,  NZB  x  W,  MRL/I,  and  male 
BXSB)  and nine imrnunologieally normal strains. In a  radioimmunoassay with anti- 
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TABLE  I 
Serum Retroviral gp 70 
Mice  Sex  Age 
1-3 Mo  4-6 Mo 
NZB  Female  42* (11):~  32 (20) 
Male  75 (14)  53 (22) 
NZB ×  W  Female  32 (28)  26 (38) 
Male  49 (31)  42 (59) 
MRL/I  Female  18 (2)  18 (23) 
Male  25 (44)  25 (48) 
BXSB  Female  11 (33)  7 (48) 
Male  17 (44)  20 (46) 
NZW  Female  41 (14)  37 (34) 
Male  69 (18)  50 (35) 
MRL/n  Female  8 (8)  6 (54) 
Male  21 (25)  13 (57) 
DBA/2  Female  17 (16)  20 (20) 
Male  28 (14)  34 (13) 
AKR  Female  8 (13)  22 (9) 
Male  11 (17)  14 (9) 
LG/J  Male  58 (13)  NT§ 
129  Male  21 (17)  NT 
C57BL/6  Female  I (9)  NT 
Male  3 (20)  NT 
C3H  Female  2 (7)  NT 
Male  5 (8)  NT 
BALB/c  Female  2 (6)  NT 
Male  2 (5)  NT 
7-9 Mo 
46 (24) 
56 (27) 
35 (t6) 
40 (27) 
7 (t2) 
23 (12) 
6 (29) 
11 (11) 
3t  (25) 
56 (24) 
5 (20) 
12 (32) 
15 (12) 
37 (12) 
12 (5) 
14 (7) 
NT 
NT 
4 (8) 
4 (7) 
3 (7) 
4 (3) 
1 (7) 
4 (5) 
* #g gp70]ml determined by a radioimmunoassay with t25I-Rauscher 
gp70 and anti-FeLV antibodies. 
Number of mice tested. 
§ Not tested. 
MuLV 
disease had  relatively high concentrations of gp70 in  their sera, but  several normal 
strains had equally high  levels (Table I). Among the SLE-prone strains, NZB  mice 
were the highest in concentration of gp70, an amount that was relatively large at only 
1 wk after birth (mean of seven mice  ±  1 SD:  24  ±  3 #g/ml). The circulating gp70 
reached  maximum  concentrations  when  the  animals  were  1  mo  old  and  did  not 
change greatly throughout  life, in contrast to the continuous increase in serum levels 
of several autoantibodies and in the frequency of glomerulonephritis as the animals 
aged (3). Similar results were obtained in NZB x W, MRL/1,  and male BXSB mice. 
Because free antibodies to AKR ecotrope gp70 have been detected in mice carrying 
AKR ecotrope viral genome (16), we used a primary binding assay and three different 
sources of retroviral protein--AKR  ecotrope gp70, Rauscher MuLV  gp70, and NZB 
xenotrope gpT0--to test the presence of serum antibodies to retroviral gp70. 
When 2 mo old, binding to 12SI-AKR ecotrope gp70 was greater in the sera of two 
SLE-prone  strains  (NZB  x  W  and  MRL/1),  as  well  as  in  several  normal  strains 
(NZW, MRL/n,  LG/J,  and  C3H),  than  in  the remaining strains tested  (Table II). 
The activity was highest in NZB x  W  mice and generally became obvious when  the 
mice were 4 wk old. After 2 mo, there was no age-dependent increase in the levels of 
anti-AKR ecotrope gp70 antibodies in contrast to the increase in anti-DNA antibodies. SHOZO  IZUI  ET  AL.  1 103 
TABLE II 
Serum Anti-Retroviral  gp  70 and Anti-DNA Activity 
Anti- 
Mice  Age  No.  Anti-AKR  Rauscher  Anti-Xeno  Anti-DNA 
NZB  x  NZW  1 wk  (5)  2.4 +  0.6*  0.4 +  0.4  NT:[:  NT 
female  2 wk  (7)  1.8 +  0.3  -0.1 +  0,1  NT  NT 
3 wk  (7)  2.6 +  0.4  0.7 +  0.5  NT  NT 
4 wk  (19)  20.5 +  9.9  3.4 +  6.2  NT  10.0 +  3.4§ 
2 mo  (21)  32.2 +  13.4  13.2 +  13.5  0.4  +  0.9  33.5 +  12.7 
5 mo  (20)  34.7 +  4.0  19.3 +  13.8  NT  45.3  +  20.6 
8-10 mo  (63)  24.5 +  8.3  4.6 +  6.2  0.5  +  1.3  69.0  +  17.1 
MRL/1  female  2wk  (8)  1.1  +  1.4  -0.5 +  0.8  1.9 ±  1.1  10.2 +  3.9 
+  male  3 wk  (5)  3.0 +  4.2  -0.6 +  0.5  1.3  +  0.7  NT 
4wk  (9)  9.1+4.5  8.6+  14.1  0.9"4-0.8  11.5 +  7.1 
2 mo  (22)  13.9 +  10.3  2.8 .4- 2.4  0.2 :t: 0.7  30.9 ::1:10.6 
4-5 mo  (23)  17.4 +  10.3  6.2 +  2.5  NT  81.2  +  11.8 
NZB female  2 wk  (7)  2.6 +  0.5  0.1  +  0.5  NT  NT 
4 wk  (8)  2.2 ::t: 0.3  -0.1 .4- 0.2  NT  12.7 .4- 5.3 
2 mo  (11)  2.2 ::1:0.9  0.3 +  0.5  NT  28.8 .4- 8.8 
10 mo  (12)  3.3 +  1.7  0.1  +  1.1  0.9  +  0.8  54.3 +  9.4 
BXSB mate  2-3 mo  (18)  0.5 .4-  1.9  0.2 +  0,5  0.4  +  0.7  16.6 .4- 9.3 
6-8 mo  (28)  1.2 +  1.9  0.5 +  1.6  -0.3 .4- 0.4  29.3 -4-  16.6 
MRL/n  female  2 mo  (10)  12.8 +  9.7  1.2 .4-  1.7  1.5  +  1.7  20,2 +  9.3 
+  male 
NZW  female  +  2 mo  (7)  10.4 +  7.5  0.4 +  1.0  0.5  .4- 0.6  10.2 -4- 4.7 
male 
LG/J  2 mo  (10)  24.1 +  8.9  9.3 +  5.0  NT  4.2  4-  1.2 
129  2 mo  (12)  0.8 +  1.2  -0.1 +  0.4  -0.1  +  0.9  8.2  +  1.3 
AKR  2 mo  (10)  -0.2 .4- 0.6  0.1  +  1.2  NT  7.5  +  2.8 
BALB/c  2 mo  (12)  0.1  +  0.9  -0.5 .4- 0.9  NT  9.1  +  2.2 
C3H  2 mo  (15)  4.7 .4- 5.0  0.1  +  0.9  NT  11.4 -4- 2.5 
C57BL]6  2 mo  (12)  -0.9 .4-  1.0  0.3 .4-  1.0  NT  11.0 .4- 2.8 
DBA/2  2 mo  (7)  -0.3 .4-  1.0  2.3 +  1.4  NT  4.9 +  2.3 
* Percent binding of l~I-gp70 by 5 #1 ofserum. Mean +  1 SD. 
:l: Not tested. 
§ Percent binding of l~I-ssDNA by 10 #1 of serum. Mean +  1 SD. 
In fact, the binding activity to AKR  ecotrope gp70 was comparatively higher in sera 
of 2-mo-old mice than in 8-mo-old mice. As might be expected, the sera from NZB or 
BXSB mice which have no AKR  ecotrope genome and therefore no exposure to AKR 
antigens, exhibited no significant binding to AKR  ecotrope gp70. 
Some  sera  from  NZB  x  W,  MRL/1,  and  LG/J  mice  also  bound  significant 
quantities of Rauscher MuLV  gp70 (Table II). Increased anti-Rauscher MuLV  gp70 
activity was found more frequently in sera from 2- and 5-mo-old NZB x W  mice than 
those from 8-mo-old mice. 
In contrast to AKR  ecotrope gp70  and  Rauscher  MuLV  gp70  activities, none of 
the sera bound significant amounts of lzSI-NZB xenotrope gp70 (Table II). These data 
clearly indicate that significant levels of anti-AKR  ecotrope gp70 and anti-Rauscher 
MuLV  gp70 antibodies are not necessarily associated with murine SLE syndrome. 
Sedimentation Rate of Serum gpTO.  Sera  from  SLE-prone  mice and  normal  mice of 
various ages were next  compared  in  terms of the sedimentation of gp70  molecules. 
After uhracentrifugation  in sucrose density gradients, the gp70 was measured in each 1104  gp70-ANTI-gp70 COMPLEXES IN MURINE LUPUS 
of 15 serial gradient fractions by the radioimmunoassay. 
In pooled sera from 1- to 3-mo-old NZB x W  female mice (50% mortality 8-9 mo 
old)  gp70 always appeared  in or near gradient fractions containing the labeled 5S 
marker (Fig. 1). In comparison, when sera from 5-mo-old mice were uhracentrifuged, 
gp70 banded  in  a  broader peak.  Although  the  peak of gp70 was  found in  the  5S 
position, significant amounts of gp70 were detected in bands heavier than 7S IgG. In 
sera  from  8-  to  10-mo-old  mice,  larger  amounts  of gp70  appeared  in  the  heavy 
fractions. When  15 individual sera of 8- to 10-too-old mice were analyzed, all had the 
heavy form of gp70, but quantities of gp70 present in the heavy position varied in 
each sample.  Although the sedimentation patterns were not  uniform, many of sera 
contained two peaks of gp70: a wide peak of 9-19S region and another peak in the 5S 
position. In some sera, only a 9-19S peak of gp70 was observed. One should note that 
the amounts of heavy gp70 increased as the animals aged and as amounts of the light 
form of gp70 decreased. This heavy gp70 appeared 2-3 mo later in the sera of male 
NZB x W  mice than in their female counterparts. 
NZB mice live longer than NZB x W  females (50%  mortality in NZB males and 
females at  16-17 mo old), and the heavy form of gp70 was detectable in NZB sera 
only after the mice reached 8-10 mo of age (Fig.  1). Even then, less heavy gp70 was 
apparent  than in NZB x  W  females of the same age.  Heavy gp70 appeared at  the 
same times in NZB males and females. 
The newly developed SLE-prone murine strain, MRL/I, that is characterized by 
an early fatal glomerulonephritis (50% mortality: 5-6 mo old for both sexes)  mani- 
fested the heavy form of gp70 earlier than NZB x W  female mice. Sera from 1.5-mo- 
old MRL/1 mice exhibited only a single peak of gp70 at about the 5S region, but by 
3 mo of age, both sexes had gp70 of the heavier variety (Fig. 1). The amounts of gp70 
present  in  the heavy fraction increased  as  the MRL/1  mice aged, similarly to the 
NZB x W  and NZB mice. On the other hand, MRL/n mice, which are a substrain of 
MRL mice and develop glomerulonephritis much later in life (50% mortality: female, 
17 mo old; male, 23 mo old), had no detectable heavy gp70 during the first 8-10 mo 
of life.  However, when  1  yr  old,  female,  but  not  male  MRL/n  mice,  expressed 
considerable heavy gp70 in their sera. 
Another newly developed SLE-prone strain, BXSB, has a.male dominant  disease 
characterized by early fatal glomerulonephritis despite low levels of anti-DNA anti- 
bodies (50% mortality: male, 6 mo old; female, 15 mo old), only males formed rapidly 
sedimenting gp70 beginning at 3 mo of age (Fig. 1). As the animals aged, an increased 
proportion of the  gp70  sedimented  toward  the  bottom  of the  gradient.  However, 
female BXSB mice, which are immunologically normal throughout the first 9 mo of 
life, developed no heavy gp70 until 8-10 mo old. 
A possibility exists that anti-Rauscher MuLV gp70 antibodies present in sera from 
2- to 3-too-old NZB x W mice and 8-too-old LG/J mice might interfere with detection 
of heavy gp70, because 125I-Rauscher MuLV gp70 was used as the labeled antigen in 
the radioimmunoassay. Therefore, selected serum samples from 3- and 8-mo-old NZB 
x  W  mice and  8-too-old  LG/J  mice which  contained  anti-Rauscher  MuLV  gp70 
antibodies were analyzed in a different radioimmunoassay using 125I-NZB xenotrope 
gp70 and anti-NZB xenotrope virus antibodies. In a serum from an 8-too-old NZB x 
W  mouse, considerable amounts of heavy gp70 were demonstrated with this assay, SHOZO IZUI ET AL.  1105 
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analyzed by sucrose density gradient ultracentrifugation. The concentration ofgp 70 was determined 
by the radioimmunoassay with anti-FeLV antiserum and l~nI-Rauscher MuLV  gp70. The position 
of markers is indicated by the arrows. 
whereas none of the sera from 3-mo-old NZB x W  or 8-mo-old LG/J mice had  the 
heavy gp70 (data not shown). 
The sedimentation pattern of serum p30 of a pooled serum from 8-mo-old NZB x 
W  female mice was compared to that of gp70. In contrast to the wide range of sizes 
found  for gp70,  all  the  p30  molecules sedimented  in  the  3-5S  gradient  fractions, 
indicating an absence of complexes containing this major viral protein. 
Characterization of Heavy Form of Serum gp TO.  Because the presence of heavy gp70 in 1106  gp70-ANTI-gp70 COMPLEXES IN MURINE LUPUS 
sera correlates well with the progression of murine SLE, the heavy gp 70 may represent 
ICs.  To examine this  possibility,  we  incubated  the  sera  with  a  Staph  A  bacterial 
absorbent, which effectively removes both IC and  IgG from serum  (20,  21).  When 
pooled sera from 8-mo-old NZB x W  female mice were absorbed with Staph A, then 
subjected to sucrose density ultracentrifugation, the heavy form ofgp70 was no longer 
detectable (Fig.  2).  However, amounts of gp70  in  the  5S  fractions were similar  to 
those in unabsorbed sera, indicating that  Staph A selectively absorbed heavy gp70. 
We then quantitated  gp70  before and  after absorbing  the sera with  Staph  A  and 
found that absorption removed -~ 50% of the circulating gp70 of 8-too-old NZB x W 
females (Table III). Considerable amounts of gp70 were also absorbed from the sera 
of 5-mo-old MRL/1, 6-mo-old male BXSB, and  10-too-old NZB mice with Staph A. 
Most of this gp70 was recovered by treating the absorbent with 2.5 M  KSCN for 30 
min at room temperature. However, Staph A did not significantly absorb gp70 from 
the sera of l-too-old mice of lupus strains or of 8- to 10-mo-old mice of normal strains 
tested (NZW and DBA/2). 
To further characterize the heavy gp70, immunoabsorptions were performed. For 
this purpose, gp70 was partially purified from sera by passage through concanavalin 
A-coupled Sepharose 4B columns and concentrated. This procedure led to about a 
fivefold increase  in  the  concentration  of gp70,  whereas  the  concentration  of IgG 
decreased >  10 times. Then, 0.05 ml of concentrated serum gp70 preparations from 
8-mo-old NZB x W  female mice were treated with 0.1  ml of rabbit anti-mouse IgG 
antibodies, which precipitated most of the IgG in the samples leaving the supernates 
to be analyzed by sucrose density gradient ultracentrifugation. Control samples were 
treated with  NRS  in a  similar manner.  In addition, comparable samples  absorbed 
with  Staph  A  were  centrifuged  in  parallel  runs  on  sucrose  density  gradients.  A 
representative experiment is shown in Fig. 3. Samples treated with anti-IgG antibodies 
did not have the heavy form of gp70 compared to those treated with NRS, although 
the amounts of gp70 in 5S regions were similar in both gradients. The distribution of 
gp70 in the gradient fractions after absorption with anti-IgG antibodies was essentially 
identical to that in samples absorbed with Staph A. Similar results were obtained in 
concentrated gp70 samples from MRL/1, BXSB, and NZB mice, although absorption 
with Staph A was generally more efficient in removing the heavy form of gp70 than 
absorption with anti-IgG antibodies. 
Our final means of establishing that the heavy gp70s were ICs was to investigate 
the effect of KSCN, an IC-dissociating agent, on heavy gp70. A serum pool from 8- 
mo-old NZB x W  female mice was subjected to ultracentrifugation on sucrose density 
gradients in the presence or absence of 0.5 M  KSCN. Treatment of sera with KSCN 
led to a disappearance of heavy gp70 but increased concentrations of gp70 in the 5S 
position compared to sera not exposed to KSCN (Fig. 4 a). Similar experiments were 
performed with partially purified, concentrated serum gp70 from 8-too-old NZB x W 
females.  All  the  gp70  shifted  to  the  5S  regions  in  gradients  containing  KSCN  in 
contrast to the diffuse distribution of gp70 when KSCN was absent  (Fig.  4 b).  IgG 
always appeared in fractions heavier than  7S as well as in  7S position of gradients 
without  KSCN,  whereas  IgG  was  located only in  the  7S  region of gradients  with 
KSCN.  When this experiment was  repeated on the  10-19S components containing 
heavy gp70 obtained  from these  gradients  without  KSCN,  the addition  of KSCN SHOZO  IZUI  ET  AL.  1107 
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FIo.  2.  Ultracentrifugation analysis of molecular size of serum gp70  before  (O)  and  after  (0) 
treatment of sera with Staph A. 0.2 ml of sera diluted one-half in 2 mg/ml BSA were incubated 
with 0.25 ml of washed, packed Staph A for 30 rain at room temperature. The position of markers 
is indicated by the arrows. 
TABLE  III 
Absorption of Serum gp70 with Staph A 
Mice  Age 
gp70 ~g/ml) 
Unabsorbed  Absorbed*  (Percent ab-  Eluate from 
sorption)  Staph A~L 
NZB  ×  NZW female  8 mo  30.4  16.2  (46.7)  12.3 
1 mo  35.0  35.8  (0)  N'I'§ 
MRL/I  female  5 mo  12.4  7.9  (36.3)  4.3 
1  mo  15.6  15.5  (0)  NT 
BXSB male  6 mo  17.5  11.3  (35.4)  6,0 
1 mo  15.8  15.4  (2.5)  NT 
NZB female  10 mo  34.1  26.5  (22.3)  5.6 
1 mo  36.2  37.8  (0)  NT 
NZW female  10 mo  47.9  47.2  (1.5)  NT 
1 mo  44.4  42.5  (4.3)  NT 
DBA/2 female  8 mo  10.5  10.8  (0)  NT 
1 mo  16.8  16.1  (3.6)  NT 
* 200 g,l of pooled sera diluted Vlo in 2 mg/ml BSA in PBS were incubated with 50 #l packed Staph A for 
30 min at room temperature. 
:~ To elute gp70 bound to Staph A, Staph A was first washed five times with 1 ml of PBS and treated with 
200/tl  of 2.5  M  KSCN  in  PBS  for 30  min at  room temperature.  Eluates were  immediately dialyzed 
against PBS. 
§ Not tested. 
caused almost all the gp70  to sediment in the 5S  regions  (Fig. 4  C).  In contrast, 
without KSCN, most of gp70 again sedimented in 10-19S regions. 
To examine whether KSCN-dissociated gp70  and Ig could reassoeiate  and form 
heavy gp70,  7S  and 5S  fractions were obtained by ultracentrifuging concentrated 
gp70 in the presence of KSCN. Both fractions were extensively dialyzed against PBS, 
mixed and incubated overnight at room temperature, then ultracentrifuged again. In 
the mixed fractions, considerable amounts of gp70 shifted toward the bottom of the 1108  gp70-ANTI-gp70 COMPLEXES  IN  MURINE LUPUS 
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Fz~.  3.  Absorption of the heavy gp70 with anti-IgG antibodies or Staph A. Partially purified and 
concentrated  gp70  from 8-raG-old  NZB x  W  female mice was  treated  with  anti-IgG antibodies 
(q~--------O), Staph  A  ((3  O)  or  NRS  (0-  -  -0)  before  the  ultracentrifugation  analysis. The 
position of markers is indicated by the arrows. 
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FIG. 4.  (A) Effect of KSCN on the molecular size of serum gp70. A pooled serum from 8-mo-old 
NZB x W female mice was subjected to sucrose density gradient ultracentrifugation in the presence 
((3) or absence  (0)  of 0.5  M  KSCN.  Fractions obtained  from KSCN-containing gradient  were 
immediately dialyzed against  PBS before the determination of gp70  content by the radioimmu- 
noassay.  (B)  Effect  of KSCN on the molecular size of serum gp70  partially purified by passage 
through concanavalin A-coupled Sepharos¢  4B. gp70 was partially purified from sera of 8-mo-old 
NZB x W female mice and subjected to ultracentrifugation in the presence  (O) or absence  (0) of 0.5 
M KSCN. (C) Dissociation  of the heavy gp70 by KSCN. The partially purified serum gp70 from 8- 
mo-old NZB x W female mice was subjected to ultracentrifugation without KSCN. Then,  10-19S 
components containing heavy gp70 were pooled and ultracentrifuged again in the presence  (O) or 
absence  (0)  of 0.5 M  KSCN. (D) Reassoeiation  of KSCN-dissociated gp70 and Ig. The partially 
purified serum gp70 from 8-mo-old  NZB x W female mice was subjected to ultracentrifugation in 
the presence of 0.5 M KSCN. 7S and 5S fractions were extensively dialyzed against PBS, mixed and 
incubated  overnight  at  room  temperature,  then  ultracentrifuged  again  without  KSCN  (0).  5S 
fractions  alone were ultracentrifuged in a parallel run ((3). The position  of markers  is indicated by 
the arrows. 
gradient,  indicating  reassociation  of recovered reactants  (Fig.  4  d).  However, such  a 
reassociation  was  completely inhibited  when  Ig, which were present  in  the mixtures, 
were removed by precipitation with anti-IgG antibodies. When  only 5S fractions were 
tested,  most of the gp70 remained  in the 5S regions. 
Quantitation of Free and Ig-Bound Serum gp70.  Concentrations of gp70 were measured 
after treatment  of individual test sera with rabbit  anti-mouse  IgG antibodies,  or as a 
control with NRS, to quantitate  free and  Ig-bound gp70.  In  1- to 3-mo-old NZB x  W 
female mice, no significant amounts  of gp70 were removed with anti-IgG antibodies 
(Fig. 5).  However, ~  30% of sera from 5-mo-old mice and  almost  all the sera from 8- 
to 10-mo-old mice lost one-fifth to one-half of their content ofgp70 through absorption 60- 
SHOZO  IZUI  ET AL.  1109 
40- 
cs. 
J-. 
ss) 
20- 
2 
•|. 
0 
0  ~l~  "  .~t~ 
I-3mo  5too 
,o  :  ° 
$-lOme  lmo  3ge  5.ilmo  l-Sma  II-lOmo  5too  5-11me  8too  8too 
NZBxW ~  MRL/I ~  BXSB  ~  NZB~  MRL/n~  BXSB9 NZW9 DBA/2~ 
I 
:  ,  ] 
lm0  3mo  5mo 
| 
q. 
FIG.  5.  Quantitation oflgG-bound serum gp70 from SLE-prone and normal mice at various ages. 
Concentrations of gp70 were determined before and after removal of serum Ig by rabbit anti-mouse 
IgG antibodies. Results are expressed as  the percentage of serum gp70  absorbed with anti-IgG 
antibodies. 
by anti-Ig. Compared to female NZB x W  mice, the males developed Ig-bound gp70 
2-3 mo later. MRL/1 and male BXSB mice had Ig-bound gp70 earlier than NZB x 
W  mice. About 70% of 5- to 8-mo-old mice had significant amounts (> 1/10) of gp70 
complexed with Ig (Fig. 5). However, no gp70 was absorbable from sera of MRL/n 
or female BXSB mice at  5-8 mo old.  In NZB  mice, the complexing of gp70  to Ig 
appeared first at 8-10 mo old, and the incidences and amounts were lower than in 
other SLE-prone strains  (Fig. 5).  In contrast, none of the sera from normal strains 
contained significant amounts of Ig-bound gp70 during the first 8-10 mo of age. 
Effect of Cyclophosphamide-Treatment on the Formation of Heavy gp 70.  The development 
of the Ig-bound, heavy form of gp70 was examined in NZB x W  females which had 
received the immunosuppressive drug, cyclophosphamide (CP) from 4 mo of age. CP 
had a dramatic effect because this treatment prolonged the animals survival time (at 
14 mo of age: CP-treated, 100% survival; untreated, 20% survival) and suppressed the 
spontaneous development of anti-DNA antibodies (percent binding of x25I-ssDNA at 
8 mo of age. CP-treated, 12.8  _+ 3.9; untreated, 70.1  4- 8.8%). However, there was no 
significant difference in serum levels of gp70 between CP-treated (21.5  4-  6.3/~g/ml) 
and  untreated  mice  (21.9  4-  8.3  /~g/ml).  The  details  of this  experiment  will  be 
described elsewhere.  2 We then compared the development of heavy gp70 in three 13- 
mo-old NZB x W  females treated with CP to that in three 8-too-old untreated mice 
of the same strain  and sex.  As analyzed after ultracentrifugation, none of the CP- 
treated mice had the heavy form of gp70 in their sera (Fig. 6); in fact, the sedimen- 
tation pattern of their serum gp70 was essentially identical to that of 2-mo-old mice. 
On the other hand, all three serum samples from untreated mice had relatively large 
amounts of gp70 in the gradient fractions heavier than 7S IgG. When the two groups 
of sera were compared after absorption, considerable amounts of gp70 from untreated 
2 Theofilopoulos, A. N.,  R. A. Eisenberg, S. Izui,  P. S. McConahey, and F. J.  Dixon.  Manuscript in 
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Fzt~. 6.  Failure to develop the heavy gpT0 in NZB x W  female mice treated with CP. Three sera 
from CP-treated mice at  13 mo of age and three from untreated mlee at 8 mo of age were subjected 
to sucrose density gradient analysis for the presence of the heavy gp70. The position of markers is 
indicated by the arrows. CP-treated: A, No.  7; C), No. 8; O, No. 9. Nontreated: C), No.  13; 0, No. 
14; A, No.  15. 
mice  were  absorbed  with  anti-IgG  antibodies  or  Staph  A,  whereas  no significant 
amounts ofgp70 from sera of  CP-treated mice were absorbed with anti-IgG antibodies 
or Staph A  (Table IV). 
Sedimentation Rate of  gp70 in Renal Eluates.  Considerable amounts of retroviral gp70 
were demonstrated in renal eluates from 2-mo-old (5 #g/g of tissue) and 8- to 10-mo- 
old NZB x W  female (16/~g/g of tissue) mice, whereas IgG was demonstrable only in 
eluates from 10-mo-old mice (590/~g/g of tissue). The distribution of gp70 as seen by 
immunofluorescence was limited to the tubules, particularly the apical portions of the 
convoluted tubules, in the 2-too-old mice but involved glomeruli as well as tubules in 
the older mice  (6,  9,  10).  When we analyzed the molecular size of this gp70, renal 
eluates from old NZB x W  mice contained some heavy gp70, although >50% of gpT0 
sedimented near the 5S regions (Fig. 7). By contrast, gp70 in renal eluates obtained 
from 2-mo-old mice sedimented only in the  5S position. This heavy gpT0 in renal 
eluates was selectively absorbed by Staph A or anti-mouse IgG antibodies. A similar 
heavy gpT0 was also found in renal eluates from  10-mo-old NZB, 6-mo-old BXSB, 
and 5-mo-old MRL/1 mice. 
Discussion 
The major envelope glycoprotein, gp70, of murine retroviruses is  present  in  the 
serum of virtually all  mice  (6,  8,  9),  but  its expression does not  correlate with  the SHOZO  IZUI ET AL. 
TABL~ IV 
Absorption of Serum gp70 with Staph A or Anti-IgG Antibodies in CP-Treated and 
Nontreated (NZB X NZW) Ft Female Mice 
1111 
Treatment 
Staph A*  Anti-IgG:~ 
Unab-  Ab-  Absorp-  Unab-  Ab-  Absorp- 
sorbed  sorbed  tion  sorbed  sorbed  tion 
(2P 
Control 
No.  %  % 
7  32.4§  31.9  1.5  30.9  32.1  0 
8  22.9  21.0  8.3  22.4  21.6  3.6 
9  20.6  19.6  4.9  21.7  20.6  5.1 
13  31.4  19.4  38.2  32.2  25.4  21.1 
14  20.0  14.3  28.5  19.4  15.8  18.6 
15  32.8  12.8  61.0  32.1  20.7  35.5 
• 200 #1 sera diluted V~o in 2 mg/ml BSA in PBS were incubated with 50 #1 packed Staph A 
for 30 min at room temperature. 
:~ 100 #1 sera diluted V2o in 2 mg/ml BSA in PBS were treated with 100 #1 rabbit anti-mouse 
IgG antibodies or NRS for 30 rain at 37°(2 and for 60 min at 4°(2. 
§ Retroviral gpT0 #g/ml determined by radioimmunoassay with I~I-Rauscher gp70 and 
anti-FeLV antibodies. 
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Fio.  7.  U]tracentrifugation ana]ysls ofmolecu]ar size ofgp70 in renal eluates obtained from 2-mo- 
old (0) and 8- to 10-mo-old (O) NZB x W female mice. The position of markers is indicated by the 
arrows. 
progression of nephritis nor of autoimmune disease in mice that  characteristically 
succumb to SLE-like symptoms (10,  16, 22, 23). However, our investigation of gp70- 
anti-gp70 ICs present in murine sera  demonstrated that  all the  SLE-prone strains 
contain considerably more complexed, heavy form of gp70 than SLE-free mice. This 
complexed gp70 varies in molecular size from 9S to  19S position on sucrose density 
gradient ultracentrifugation. Unlike the 5S gp70, the heavy gp70 increases not only 
in incidence, but also in amounts with the progression of disease in all the SLE strains, 
although the total levels of serum gp70 do not change after the animals reach  1 mo 1112  gp70-ANTl-gp70 COMPLEXES IN MURINE LUPUS 
of age.  The appearance of heavy gp70 varies with age among the SLE susceptible 
strains, but parallels the onset of renal disease and persists throughout the course of 
disease.  In  fact, MRL/1  and  BXSB mice, which have a  50% mortality at 5-6 too, 
develop the heavy gp70 in their sera earlier than other SLE mice do. Similarly, heavy 
gp70 appears in sera of female NZB x W  mice earlier than in the males. However, a 
substrain of MRL mice, MRL/n, and female BXSB mice, which develop glomeru- 
lonephritis in the 2nd yr of life with a  50% mortality at >15 mo, fail to develop the 
heavy gp70 during the  first 8-10 mo of age.  In contrast, sera from other immuno- 
logically normal strains with high concentrations of gp70, such as NZW, LG/J, and 
DBA/2 mice, have no heavy gp70, at least during the first 8-10 mo of life. 
Several findings suggest that this heavy form of gp70 is a complex with antibodies 
to the viral protein. First, the heavy form of gp70 is selectively absorbed with anti- 
IgG antibodies as well as Staph A. The appearance of Ig-bound gp70 complexes in 
sera is concomitant with that of heavy gp70, and the degree of gp70 sedimented in 
the heavy position of gradients correlates with the amounts of gp70 absorbable with 
anti-IgG  antibodies  or  Staph  A.  Second,  these  complexes  are  dissociated  by  a 
chaotropic ion,  KSCN,  and  when  the reactants  recovered from  7S  regions and  5S 
regions of KSCN gradients are mixed under associating conditions, they recombine 
and  form the heavy gp70. The facts that  the reassociation of recovered reactants is 
completely inhibited when IgG is removed from the reactants and that components 
obtained from 5S regions do not  form the heavy gp70 by themselves, indicate that 
IgG is required to form the heavy form of gp70. Finally, the finding that  NZB x W 
females treated with an immunosuppressive drug, CP, have no heavy gp70 even at  1 
yr  of age,.but  still  have  levels  of gp70  as  high  as  untreated  mice  supports  an 
immunologic mechanism for the development of heavy gp70. 
Because antibodies  to viral envelope components of MuLV  were previously ob- 
served in sera from NZB and NZB x W  mice (16,  24), in the present study, serum 
levels of antibodies against  three antigenically different gp70 were measured. It was 
clear  that  all  strains  of mice  with  AKR  ecotrope  genome spontaneously  develop 
antibodies against  AKR ecotrope gp70  (16).  Among these strains,  NZB x  W  mice 
formed the greatest amount of antibody. In addition, some NZB x W, MRL/1, and 
LG/J mice produced antibodies reacting with anti-Rauscher MuLV gp70. However, 
in view of the facts that  (a) the serum titers of these antibodies do not correlate with 
the progression of disease:  (b)  NZB  mice and  BXSB males,  which  develop the Ig- 
bound, heavy gp70, do not have detectable amounts of anti-AKR ecotrope or anti- 
Rauscher MuLV gp70 antibodies; (c) several immunologically normal murine strains 
spontaneously develop these antibodies;  and  (d)  these antibodies were not concen- 
trated in renal eluates from any of SLE strains (10), it appears that anti-AKR ecotrope 
or anti-Rauscher MuLV gp70 antibodies are not involved in the formation of gp70 
ICs. 
In view of the lack of correlation between anti-AKR and Rauscher gp70 antibodies 
and the formation of gp70 ICs, it is most likely that the antibody involved is directed 
to xenotropic gp70 which is the usual kind of gp70 in the serum of virtually all mice 
(36). If this is the case, the mice which develop SLE would not have a unique kind or 
amount of gp70 but instead, they would have the unique ability to make an antibody 
response to the ubiquitous  molecule perhaps  as part  of their general  immunologic 
hyperresponsiveness. Possible bases for such a hyperresponsiveness of SLE-prone mice SHOZO  IZUI  ET  AL.  1 1 13 
have been suggested  (25-30), for example, loss of suppressor T  cells (31, 32) and/or 
increased B cell activity (22, 33, 34). Alternatively, SLE mice might produce a unique 
and as yet undiscovered form of retroviral gp70 during the course of disease, possibly 
as a result of an abnormality in genes that regulate expression of retroviral gp70 or a 
recombination event, e.g., between ecotrope virus and xenotrope virus as observed in 
mink cell focus-inducing viruses (35). 
The presence of retroviral gp70 ICs in sera and tissue lesions does not imply that 
retroviral production is involved in the disease of SLE mice, because the expression of 
retroviral gp70 may occur independently of complete virus production as in the case 
of serum gp70 (8, 36). Indeed, no consistent pattern has been found in the virologic 
phenotypes of four different SLE strains (16, 37). Recently, Datta et al.  (38) demon- 
strated that the phenotypic expression of xenotropic viruses was unrelated to glomer- 
ulonephritis in crosses between NZB and SWR mice. However, one cannot exclude 
the possibility that the production of other as yet unrecognized kinds of retroviruses 
might be involved in murine SLE. 
Our results strongly suggest that circulating gp70 ICs are a potential source of tissue 
injury in all mice with SLE. The presence of the complexed form of gp70 in renal 
eluates from the diseased kidneys of adult mice but not in those from 2-too-old mice 
also  supports  the  involvement  of these  gp70  ICs  in  the  renal  lesions.  It  is  also 
noteworthy that in the sera, we did not find a heavy form of p30, the major structural 
protein of retroviruses. This is compatible with the previous observations of relatively 
infrequent deposits of p30 in glomerular lesions (6,  10). 
Our observation, however, does not imply that gpT0 ICs are the primary or major 
cause  of glomerulonephritis  in  SLE  strains.  As  described  previously,  lupus  mice 
produce a  variety of antibodies reactive with native or altered autologous antigens 
(3-5,  10, 39). A number of these antibodies seem to be involved in the pathogenesis 
of murine  SLE  through  the  combination  with  soluble  tissue  antigens  released  in 
circulating blood or in extravascular spaces to form ICs resulting in tissue damage. In 
fact, unidentified circulating IC-like materials have been found in sera from SLE mice 
by a  Raji-cell assay (10) and conglutinin-binding assay (40), and significant concen- 
trations of anti-DNA antibodies in the renal eluates were demonstrated in these mice 
(4,  10). The induction of tolerance to DNA antigen in NZB x W  mice was shown to 
prolong survival  and  decrease nephritis  as  well  as  anti-DNA  production  (41,  42), 
supporting the pathological importance of DNA-anti-DNA complexes in SLE mice. 
Therefore, it will be necessary to quantitate the amounts of gp70 ICs in the serum 
and tissue lesions in relation to other ICs to determine the magnitude of the role of 
gp70  ICs.  However, the present  study clearly shows  that  the  Ig-complexed, heavy 
form of gp70 is a new useful marker of murine SLE. 
Summary 
Endogenous retroviral gp70 was investigated as a  participant in the pathogenesis 
of a lupus-like disease that spontaneously develops in four kinds of mice (NZB, NZB 
x W, MRL/1, and male BXSB). Sera from these strains contain a heavy form of gp70 
that varies in sedimentation rates from 9S to 19S in sucrose density gradient analysis 
and appears with the onset of disease and persists throughout its course. Immunolog- 
ically normal strains of mice do not develop rapidly sedimenting gp70 by 8-10 mo of 
life. The fact that the heavy gp70 is selectively absorbed with anti-IgG antibodies or 1114  gp70-ANTI-gp70 COMPLEXES  IN MURINE LUPUS 
with Staphylococcus aureus protein A  suggests that it is complexed with antibodies. The 
incidence and quantities  of these gp70 ICs rise with the progression of disease in all 
strains  with  lupus.  These  findings  suggest  that  Ig-complexed  heavy gp70  may  be 
involved in the pathogenesis of glomerulonephritis of mice with SLE. 
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